Clinical Trial Update: Subcutaneous Immunoglobulin for Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) [NA]

View source ↗

Summary

The University of South Florida completed a clinical trial evaluating subcutaneous immunoglobulin for chronic inflammatory demyelinating polyneuropathy, and the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy

Drugs mentioned

• Subcutaneous immunoglobulin (immunoglobulin)

Snippet

Sponsor: University of South Florida | Conditions: Chronic Inflammatory Demyelinating Polyneuropathy | NA | Status: COMPLETED | Results posted: 2024-10-08